20 LATEST RESOURCES (93 INDEXED)
Feasibility of Remote Interviews in Assessing Disease Severity in Patients with Major Depressive Disorder: A Pilot Study · January 2024
Articles
Neuropsychopharmacology Reports
A Multicenter, Single-Arm, Open-Label Interventional Study of Adherence to Brexpiprazole during Switching from Previous Antipsychotic Drugs in Patients with Schizophrenia or Schizoaffective Disorder · January 2024
Articles
Neuropsychopharmacology Reports
Asenapine versus Olanzapine for the Treatment of Nausea and Vomiting in Patients with Cancer: A Retrospective Study · January 2024
Articles
Neuropsychopharmacology Reports
Comparison of Brexpiprazole, Aripiprazole, and Placebo for Japanese Major Depressive Disorder: A Systematic Review and Network Meta-Analysis · January 2024
Articles
Neuropsychopharmacology Reports
Long-Acting Injectable Antipsychotics as Maintenance Therapy for Schizophrenia during the COVID-19 Pandemic: A Micro-Narrative Review · January 2024
Articles
Neuropsychopharmacology Reports
Management of Unspecified Anxiety Disorder: Expert Consensus · February 2023
Articles
Neuropsychopharmacology Reports
Analysis of the Effect of Brexpiprazole on Sleep Architecture in Patients with Schizophrenia: A Preliminary Study · January 2023
Articles
Neuropsychopharmacology Reports
The Management Challenges of a Case with Flupentixol-Induced Neuroleptic Malignant Syndrome · December 2022
Articles
Neuropsychopharmacology Reports
Age at Onset of Alcohol Consumption and Its Association with Alcohol Misuse in Adulthood · December 2022
Articles
Neuropsychopharmacology Reports
Attention-Deficit Hyperactivity Symptoms and Risk of Alcohol Use Relapse · December 2022
Articles
Neuropsychopharmacology Reports
Risk Factors for Cannabis Use Disorders and Cannabis Psychosis in Japan: Second Report of a Survey on Cannabis-Related Health Problems among Community Cannabis Users Using Social Networking Services · December 2022
Articles
Neuropsychopharmacology Reports
A Case of Postpsychotic Depression Improved by Switching Antipsychotic Monotherapy · December 2022
Articles
Neuropsychopharmacology Reports
Satisfaction with Web-Based Courses on Clinical Practice Guidelines for Psychiatrists: Findings from the “Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)” Project · November 2022
Articles
Neuropsychopharmacology Reports
Plasma Neuropeptide Levels in Patients with Schizophrenia, Bipolar Disorder, or Major Depressive Disorder and Healthy Controls: A Multiplex Immunoassay Study · November 2022
Articles
Neuropsychopharmacology Reports
The Effect of Peer Education Compared to Education Provided by Healthcare Providers on Premenstrual Syndrome in High School Students: A Social Network-Based Quasi-Experimental Controlled Trial · November 2022
Articles
Neuropsychopharmacology Reports
Predictors of Response to Pharmacotherapy in Children and Adolescents with Psychiatric Disorders: A Combined Post Hoc Analysis of Four Clinical Trial Data · November 2022
Articles
Neuropsychopharmacology Reports
Risk Assessment of Accidental Falls in Patients Taking Trazodone, Quetiapine, or Risperidone for Insomnia: A Single-Center, Case–Control Study · November 2022
Articles
Neuropsychopharmacology Reports
What Outcomes in Community Mental Health Research Are Important to Caregivers of People with Schizophrenia? An Exploratory Qualitative Analysis of an Online Survey · October 2022
Articles
Neuropsychopharmacology Reports
Association between Functional Recovery and Medication Adherence in Schizophrenia · October 2022
Articles
Neuropsychopharmacology Reports